Medical device manufacturers face mounting pressure to deliver innovative products while reducing costs and improving margins. To meet these challenges, many original equipment manufacturers (OEMs) outsource critical operations such as
Continue Reading Building Strong Medtech Partnerships: Keys to Successful Contract Manufacturing Agreements
After several years of volatility and unfavorable market dynamics, the initial public offering (IPO) market for medical technology companies is beginning to reopen meaningfully. Following the most recent IPO boom
Continue Reading From Innovation to IPO: A Strategic Checklist for Medtech Companies
The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging
Continue Reading Building a Future-Proof IP Strategy for AI in Medtech
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their
Continue Reading Why Patent Portfolios are Crucial for Life Science Innovators
The GT Tel Aviv team of attorneys is pleased to have received top recognition by the Legally Israel 100 league table. Our team is ranked across 10 areas, in addition
Continue Reading GT Tel Aviv Ranked in 10 Areas by Legally Israel 100 League Table
Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on
Continue Reading Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering
Israeli business Journal Globes recently reported 2020 to be a record-breaking year for Israeli companies raising capital on the New York and Tel Aviv Stock Exchanges.
Since the beginning of
Continue Reading Over US $8 Billion Raised by Israeli Companies in 2020 on Public Markets
GT Tel Aviv client Nym Health (“Nym”) recently announced that Geisinger is deploying the company’s autonomous medical coding technology to all nine of its hospital emergency departments. Nym, a pioneer
Continue Reading Tel Aviv Client’s Autonomous Medical Coding Technology to be Deployed by Geisinger Hospitals
As part of their free Lunch & Learn speaker series, Jewish National Fund-USA (JNF-USA) will be hosting a discussion about innovation in the realms of biotechnology, pharmaceuticals, and agricultural technology
Continue Reading Bob Grossman to Moderate JNF’s Virtual Event on US-Israeli Innovations in the Life Sciences
U.S. life sciences companies with ties overseas can be encouraged by a recent federal ruling that denied the request of foreign companies to conduct discovery in the United States in
Continue Reading Federal Court Denies Request of Foreign Companies to Conduct Discovery in the United States in Aid of a Foreign-Seated Arbitration